• Liam Noah posted an update in the group Group logo of HealthHealth 2 years, 7 months ago

    A Questionable 3-Year-Study Is Indicating That Common Diabetes Drug, Canagliflozin, With Brand Name, Invokana Could Also Reduce Risks Of Kidney Diseases And Cardiovascular Deaths In Folks With Type 2 Diabetes And Chronic Kidney Disease. But The Side Effects Of Invokana Could Be An Increased Risk Of Lower Limb Amputation And Bone Fracture.

About us   |  FAQ  |  Contact us   |  Copyright ©2021  DiscoveryBit.com  |   Privacy  |   Terms of Service

Do NOT follow this link or you will be banned from the site! This is a social network for those interested in unique and valuable information!

Log in with your credentials


Forgot your details?

Create Account